IL Science Co. Ltd Cash Flow-to-Debt Ratio
IL Science Co. Ltd cash flow-to-debt ratio. IL Science Co. Ltd (307180) has a Cash Flow-to-Debt Ratio of 0.02x as of September 2025, meaning its operating cash flow of ₩1.94 Billion could theoretically repay 0% of its total liabilities (₩125.87 Billion) in one year. Check IL Science Co. Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of IL Science Co. Ltd (2018–2024)
Cash flow-to-debt ratio of IL Science Co. Ltd from 2018 to 2024. Historical debt coverage capacity for IL Science Co. Ltd across 7 annual periods. Check IL Science Co. Ltd (307180) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
IL Science Co. Ltd Cash Flow-to-Debt Ratio by Year (2018–2024)
IL Science Co. Ltd cash flow-to-debt ratio by year from 2018 to 2024. Year-by-year debt coverage analysis for IL Science Co. Ltd. For the full cash flow conversion analysis, see how efficiently does IL Science Co. Ltd generate cash.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.03x | ₩-3.98 Billion | ₩126.27 Billion | ▲ +60.7% |
| 2023 | -0.08x | ₩-5.21 Billion | ₩64.95 Billion | ▼ -394.1% |
| 2022 | 0.03x | ₩1.56 Billion | ₩57.10 Billion | ▲ +124.9% |
| 2021 | -0.11x | ₩-7.12 Billion | ₩64.87 Billion | ▲ +30.2% |
| 2020 | -0.16x | ₩-4.92 Billion | ₩31.28 Billion | ▼ -198.8% |
| 2019 | -0.05x | ₩-792.00 Million | ₩15.04 Billion | ▲ +58.7% |
| 2018 | -0.13x | ₩-156.89 Million | ₩1.23 Billion | — |